Although marked changes in collagen can be observed in a number of clinical conditions, initial studies of the metabolic turnover of collagen suggested that this protein was metabolically more stable than other body proteins and that perhaps it was metabolically inert. After injecting glycine-C14 into rats, Neuberger, Slack (2), and Perrone (3) found that much less radioactivity was incorporated into collagen than into liver proteins. In addition, they found that the small amount of glycine-Cl" that did enter collagen disappeared with a half-life of over six weeks in young rats and longer in old rats. Subsequently, a number of investigators (4, 5) demonstrated rapid turnover rates in the small amount of "soluble" collagen which can be extracted from most tissues and is a precursor of insoluble collagen. Significant degradation of collagen, however, was not evident in studies performed directly on normal tissues. Recently, Lindstedt and Prockop (6) attempted to study the metabolic turnover of collagen by injecting proline-Cl" into rats and then following the specific activity of urine hydroxyproline-C14. Since nearly all the hydroxyproline in vertebrates is found in collagen, and since the only source of this amino acid appears to be the hydroxylation of "bound" proline in situ (7, 8) , the decay of urine hydroxyproline-C14 was assumed to reflect the degradation in vivo of collagen or its immediate precursors. The results suggested that although most of body collagen is metabolically stable, there are forms that are both synthesized and degraded rapidly under normal conditions. * Submitted for publication August 9, 1963; accepted November 14, 1963. A preliminary report of this work has been presented (1). The studies were supported in part by U. S. Public Health Service grants A-5978 and AM-K3-14,916 from the National Institute of Arthritis and Metabolic Diseases.
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In the present study an attempt was made to identify further the metabolically active forms of collagen and to verify previous suggestions that urine hydroxyproline originates from the degradation of body collagen.
Methods
Albino male Sprague-Dawley rats 3 to 4 weeks old were used in the experiments. The rats were maintained on a diet 1 adequate for normal growth but containing no hydroxyproline. They were placed in metabolic cages, and after acclimatization for 4 to 5 days, they were injected with 25 /Ac of uniformly labeled proline-C"4, 10 /c per mole,2 in 1 ml of 0.9% NaCl. The proline-C1 had been previously chromatographed with carrier hydroxyproline and found to contain less than 0.01% hydroxyproline-C' (6) . Urine was collected under toluene at 24-hour intervals except that with two rats the collections were for 15 hours only.
The rats were decapitated, the hair was shaved off, and the skin was taken for the extraction of soluble and insoluble collagen. The remainder of the animal, here referred to as "carcass," was prepared separately for the extraction of soluble and insoluble collagen. In preliminary experiments a Waring blendor and a Lourdes homogenizer were employed to homogenize the samples, but subsequently a meat grinder cooled with dry ice (9) was used. The homogenates were immediately placed in 5 vol of 0.9% NaCl and extracted on a rotatory shaker at 40 C for 24 hours. The samples were then centrifuged at 20,000 X g for 1 hour, and the supernatant solutions were taken for assay of soluble collagen hydroxyproline (infra). Fats were removed from the residue by extracting twice with 5 vol of absolute ethanol and then with 5 vol of boiling ethanol: ether (1: 2). The extracts were discarded, and the insoluble collagen in the residue was solubilized as gelatin by adding 20 vol of water and autoclaving at 124°f or 1 hour. The remaining insoluble residue was removed from the gelatin solution by filtering with a Buchner funnel. The soluble collagen 8 extract was dialyzed against 20 1 Nutritional Biochemical Corp., Cleveland, Ohio.
vol of distilled water at 40 C overnight, and then it was evaporated to dryness with a rotatory evaporator in vacuo at 1000. The samples were hydrolyzed by adding ten times the original tissue volume of 6 N HCl and autoclaving at 1240 for 15 hours. The hydrolysates were evaporated to dryness, adjusted to pH 7 with NaOH, and chromatographed on a cation exchange resin column.4 developed with 1.5 N HCl (6) . The eluted fractions were assayed for hydroxyproline by procedure II of Prockop and Udenfriend (10) , and the tubes containing hydroxyproline were pooled for quantitative assay (10) and for determination of hydroxyproline-C1" specific activity (11) . In a number of experiments the hydroxyproline-C4 fractions isolated from the column were treated with nitrous acid (12) to destroy nonpyrrolidine amino acids. The samples were then passed through the same type of cation exchange resin column a second time, and they were eluted with 1.5 N NH4OH.
The assays for hydroxyproline-C14 specific activity were then repeated.
Fractions of the gelatinized insoluble collagen 5 were hydrolyzed with equal volumes of concentrated HCl at 124°for 15 hours, evaporated to dryness, and assayed directly for hydroxyproline content (10) and for hydroxyproline-C1' specific activity (11) . Hydroxyproline assays on urine samples were performed as described previously (6) . Because samples collected during the first 7 days after the isotope administration contained large amounts of proline-C14, the hydroxyproline in these samples was separated from proline on a cation exchange resin column before assay (6) .
Recoveries based on the addition of hydroxyproline internal standards were 92 to 102% in the quantitative assays by procedure II (10) . In the assays of hydroxyproline-C4 specific activity, comparison of the amounts of isolated pyrrole with the results of the quantitative assay indicated an over-all yield of 50 to 85% in most instances, but occasionally yields as low as 25% were encountered (vide infra). By repeating the assays with different amounts of oxidant (10, 11) Assay of hydroxyproline-C14 specific activity.
The procedure employed for the assay of hydroxyproline-C14 specific activity (11) (11) . Accordingly, the assay can give erroneously high values for specific activity if the samples contain large amounts of radioactivity in materials other than hydroxyproline, but erroneously low values for specific activity are unlikely.
In the assays of the specific activity of urine hydroxyproline, 100 to 400 jug equivalents or 0.8 to 3 ,umoles of pyrrole was readily isolated from individual samples, although occasionally assays had to be repeated with different amounts of oxidant (11) to improve the yields. Similarly, little difficulty was encountered in assaying the specific activity of hydroxyproline of the insoluble collagen in skin or carcass samples, and from 100 to 2,000 ,ug equivalents of pyrrole was obtained. "Blanks" for these assays were generally less than three times the background of the liquid scintillation counter (11 to 14 cpm), and the observed radioactivity in the pyrrole was more than ten times the level in the blanks. Repeated assays on the same samples agreed within 5%.
Initially, considerable difficulty was encountered in assaying the specific activity of hydroxyproline from the soluble collagen fractions, particularly with the carcass soluble collagen. Because of the large amounts of materials other than hydroxyproline in the samples, direct assay on the hydrolysates gave low yields of pyrrole, high radioactive "blanks," and considerably higher values for specific activity than were obtained after partial isolation of the hydroxyproline. Assays on the hydroxyproline fractions obtained after column chromatography were more satisfactory. Adtquate yields of pyrrole were obtained more consistently after the column fractions were treated with nitrous acid, but there was no significant Specific activity of urine hydroxyproline-C'4. Rats were injected with proline-C14, and the specific activity of urine hydroxyproline-C14 was determined in 15-or 24-hour samples collected after 15 hours, 24 hours, six days, and 28 days (Table II) . Peak labeling of the urine hydroxyproline-C14 probably occurred in less than 15 hours, since the specific activities of samples collected over the first 15 hours were greater than the values for samples collected over the first 24 hours. As reported previously, the specific activity of urine hydroxyproline decreased rapidly during the first week after the proline-C14 administration, and a further decrease was observed after the first week (6). Little additional decrease occurred after 3 weeks, and the specific activity of successive 24-hour urine samples collected from the same rats between days 26 and 28 varied by less than 0.1 dpm per ug.
The specific activity of the urine hydroxyproline was significantly less when the subcutaneous rather than the intraperitoneal route of administration was employed (see rat III in Table III), but when the same route of administration was employed, the values were comparable to those reported previously (6) .
Comparison of collagen and urine hydroxyproline-C14. Because of variations in the degree of collagen labeling in individual animals (vide infra), the specific activity of urine hydroxyproline at various times was compared only with the specific activity of the collagen hydroxyproline isolated from the same animal (Table III) . In the two rats killed 15 hours after the C14 injection, the specific activity of the hydroxyproline in soluble collagen of the skin and the carcass was about twice the specific activity of the hydroxyproline in the insoluble collagen fractions. In both of these animals the specific activity of urine hydroxyproline was about three times the specific activity of the hydroxyproline in insoluble collagen and one and one-half times the specific activity of the hydroxyproline in the soluble collagen. In the one animal examined after 24 hours, the specific activity of hydroxyproline in the insoluble collagen and in urine was considerably less than in the animals killed after 15 hours, probably because a subcutaneous rather than intraperitoneal injection was employed. Table I ). t Proline-C'4 was administered by subcutaneous rather than intraperitoneal injection.
In the two rats examined 7 days after the proline-C14 injection, the specific activity of hydroxyproline in skin soluble collagen was about 25%, and the carcass soluble collagen was 73 to 90% of the specific activity of the hydroxyproline in the insoluble collagen fractions. The specific activity of the soluble collagen from the carcass fraction was over three times the specific activity of the hydroxyproline from the skin soluble collagen, although these fractions had comparable values in animals examined within 24 hours. The specific activity of the urine hydroxyproline was approximately equal to that of the hydroxyproline in the insoluble collagen, and four to five times greater than that of the hydroxyproline in the skin soluble collagen fraction. Comparable values for the specific activity of hydroxyproline from insoluble collagen and urine were found in two rats examined after 6 days, and in rat V the observed specific activities of hydroxyproline in the soluble collagen fractions were similar, even though the level of confidence in these values is less than for the values obtained for rats VI and VII.
In the two rats in which all four collagen fractions were examined after 28 days, the specific activities of the hydroxyproline in the soluble collagen fractions were less than one-fifth of that in the inisoluble collagen, and they were one-third to one-fifth the specific activity of the urine hydroxyproline. In rats X and XI, the specific activities of the skin soluble collagen were somewhat higher, but the results obtained in the assays were not entirely satisfactory, and the specific activity of the soluble collagen was still considerably less than the specific activity of either the insoluble collagen or urine hydroxyproline in these animals. In the six rats killed after 28 to 31 days, the specific activity of the urine hydroxyproline was 56 to 74%o of the mean specific activity of the hydroxyproline in the insoluble collagen fractions.
When rats X and XI were killed, a femur from each was removed and assayed separately for insoluble collagen hydroxyproline. The specific activities of hydroxyproline were 2.6 and 1.9, respectively, or within 10o% of the value obtained for the hydroxyproline in the carcass insoluble collagen from these animals.
Discussion
Several problems are encountered in attempting to measure the metabolic turnover of collagen with the same isotopic techniques that have been used for other body constituents. The bulk of body collagen is slowly metabolized, and it is poorly labeled by the single, acute administration of isotope usually employed (14) . As a result, significant changes in the label can be obscured by variations in the amounts of isotope initially incorporated by individual animals. In addition, the collagen of the body or even of a single tissue cannot be regarded as a single homogeneous pool, since most tissues contain a variety of soluble collagens having different turnover rates (15) . The technique of administering labeled proline and following the specific activity of urine hydroxyproline offers several advantages over earlier methods of studying body collagen. All the measurements can be made in a single animal, and apparently the catabolic products of collagen degradation can be examined selectively. The technique involves the assumption that the endogenous hydroxyproline in urine, most of which is in a peptide-bound form (16) , originates from the degradation of collagen. Earlier evidence in favor of this assumption has been summarized (16, 17) and is supported by recent reports (18, 19) indicating that the amino acid composition of the hydroxyproline peptides excreted in urine is consistent with the amino acid composition of collagen.
Initial studies (6) on urine hydroxyproline-C14 demonstrated at least three separate components in the excretion curves, thus indicating the presence of at least three different hydroxyproline pools with half-lives of about 1 day, 5 days, and 50 to 100 days. Comparison of the data with previously published observations on the metabolic turnover of various collagen fractions suggested that the first two hydroxyproline pools probably represented forms of soluble collagen, and that the third pool was probably identical with insoluble collagen. In general, the results obtained here support these conclusions, since 15 hours after administration of the proline-C14 the specific activity of urine hydroxyproline was comparable to that of soluble collagen hydroxyproline, and 28 days after the isotope was adminis-tered, the specific activity of urine hydroxyproline was comparable to that of insoluble collagen hydroxyproline. The correlation between urine and collagen specific activities was not exact, but notice must be taken of the fact that in animals killed within 1 week, significant changes in collagen specific activity occurred during the interval required for an adequate urine collection. Jackson and Bentley (15) found that the specific activity of collagen soluble in cold 0.14 M NaCi reached a maximum within 8 hours, and then it decreased rapidly. Accordingly, the specific activity of soluble collagen observed at 15 hours is probably less than the average value for this fraction during the 15 hours in which the first urine sample was collected. The evidence that peak labeling of urine hydroxyproline occurred in less than 15 hours is consistent with this conclusion. The small discrepancies between the urine and collagen hydroxyproline-C14 in rats killed after 6 or 7 days may also be explained by the possibility that significant decreases occurred in the specific activities of collagen fractions during the time required to collect the urine samples. However, the urine hydroxyproline-C14 may possibly originate from a collagen fraction which is an intermediate between soluble and insoluble collagen, and 1 to 7 days after the administration of the proline-C14 this internmediate fraction may have a higher specific activity than either of the two fractions isolated here. 5 The results obtained in animals killed after 4 weeks are of interest in several special respects. The urine hydroxyproline-C14 excreted at this time could not have originated from the degradation of soluble collagen, since the specific activity of the urine hydroxyproline in these animals was significantly greater than the specific activity of the soluble collagen. Similarly, precursors of soluble collagen were unlikely to have contributed significantly to urine hydroxyproline-C14, since the specific activity of any precursors can be assumed to be less than that of the soluble collagen. The specific activity of the insoluble collagen, however, was greater than that of the urine hydroxyproline, and therefore the results support the previous suggestion (6) that significant amounts of urine hydroxyproline peptides originate from the degradation of insoluble collagen.
The low specific activity of the soluble collagen fraction after 4 weeks indicates that little further labeling of collagen was occurring at this time.
The specific activity of the soluble collagen isolated can probably be assumed to reflect the specific activity of all hydroxyproline-containing precursors of insoluble collagen, and therefore the fractional contribution of insoluble collagen to urine hydroxyproline can be estimated from the formula, f1xl + f2x2 = 3
[1] where f1 is the fractional contribution of hydroxyproline pools other than insoluble collagen to urine hydroxyproline-C14, f2 is the fractional contribution of insoluble collagen, and xl, x., and x3 are the specific activities of the hydroxyproline-C14 in body pools other than insoluble collagen, in insoluble collagen, and in urine, respectively. By definition, fl + f2 = 1.00, [2] and when appropriate values for x1, x2, and x,' are substituted, Equations 1 and 2 indicate that 57% of the hydroxyproline-C14 excreted during day 28 by rat VIII was derived from insoluble collagen. Similarly, 70% of the hydroxyproline-C14 excreted by rat IX during day 28 was derived from insoluble collagen.
The results do not indicate whether insoluble collagen is directly degraded to urine peptides or whether insoluble collagen is first converted to more soluble forms of collagen before degradation (15) . Also, there is no indication whether the insoluble collagen in all tissues and organs is degraded to urine hydroxyproline at the same rate. Most of the hydroxyproline excreted may originate from a single tissue such as bone, but in two rats killed after four weeks, the specific activities of the insoluble collagen from skin, carcass, and bone were similar. Therefore, under the conditions studied here urine hydroxyproline-C14 probably originated from the degradation of the insoluble collagen of a number of different tissues, and the metabolic turnover of body collagen as a whole can be summarized by the general scheme shown in Figure 1 .
Recently For example, increased excretion of hydroxyproline was not observed during postpartum involution of the uterus in pregnant rats (26) or during resorption of carrageenan granulomas (21) , even though considerable amounts of collagen disappeared from the tissues. The sensitivity with which hydroxyproline excretion reflects changes in collagen metabolism depends in part on the completeness with which the hydroxyproline peptides released during collagen degradation are excreted in urine rather than being degraded further to other amino acids, carbon dioxide, and urea ( Figure 1) . No direct measurements are available on the relative fraction of hydroxyproline excreted during collagen degradation, but an approximation can be made from the available data. The half-life of insoluble collagen in young adult rats is 50 to 100 days (2, 3, 6) , and if the highest yields in Table I are accepted as the most accurate,6 the total body content of insoluble collagen hydroxyproline in these rats was about 1.2 g. If all the hydroxyproline from the breakdown of insoluble collagen were excreted, the rats should excrete 5 to 12 mg of hydroxyproline per day. Since the actual excretion rates observed were about 0.9 mg per day (6), and since only about two-thirds of this amount originated from insoluble collagen (supra), the data suggest that only 5 to 10% of the hydroxyproline released by the degradation of insoluble collagen was excreted under normal conditions. Although this estimate is only approximate, and although it applies only to insoluble collagen, it probably explains the failure to observe changes in hydroxyproline excretion in postpartum rats or in animals with carrageenan granulomas. Also, it suggests that relatively large changes in the rate of collagen degradation are required to produce significant changes in the amount of hydroxyproline excreted in urine. Summary Proline-C14 was injected into young rats, and the specific activity of the hydroxyproline-C14 excreted in urine was compared with the specific activity of hydroxyproline-C4 in soluble and insoluble collagen. Fifteen hours after the proline-C14 injection, the specific activity of urine hydroxyproline-C14 was comparable to specific activity of hydroxyproline-Cl4 in soluble collagen. Four weeks after administration of the isotope, the specific activity of urine hydroxyproline was considerably greater than the specific activity of hydroxyproline in soluble collagen but somewhat less than the specific activity of hydroxyproline in insoluble collagen. The results suggest that the endogenous hydroxyproline peptides excreted in urine originate from the degradation of both soluble and insoluble collagen. An estimate of the fractional recovery of insoluble collageni hydroxyproline as urine hydroxyproline suggests that relatively large changes in the rate of collagen degradation are required to produce significant changes in the amount of imiiino acid excreted in urine.
